About TOLKA.AI INC
Tolka AI Therapeutics is a company focused on developing personalized phage therapy for hard-to-treat infections like Mycobacterium abscessus complex pulmonary disease (MABC-PD). The company combines agentic AI, robotic manufacturing, and bacteriophages to create tailored therapies for patients left behind by traditional drug development.
Development of personalized phage therapyUse of agentic AI in drug developmentRobotic manufacturing of phage therapiesOptimization of phage cocktailsGeneration of superphagesGMP-grade phage manufacturingHigh-throughput microbiology workflow automation
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| SBIR NEW AWARD TO TOLKA.AI | Department of Health and Human Services | $300K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to TOLKA.AI INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.